{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:08:57Z","timestamp":1784660937300,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Esophageal carcinoma is the highly lethal cancer in the world, predominantly in some areas of East Asia. We previously reported that overexpression of cytoskeleton regulator Wiskott-Aldrich syndrome protein and SCAR Homolog (WASH) associates with poor prognosis of patients with esophageal squamous cell carcinoma (ESCC). However, the molecular mechanism and clinical significance involved in WASH overexpression have not been fully elucidated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Bioinformatics analysis and luciferase reporter assay were used to predict and validate miR-637 as a regulator of WASH in ESCC cell lines. qRT-PCR, Western blotting and ELISA assays were performed to examine RNA expression and protein levels, respectively. Next, the biological functions of miR-637 were explored by tumor sphere formation assay in vitro and nude mouse tumor xenograft in vivo. Finally, we evaluated the association of miR-637 levels with clinical features in ESCC patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified miR-637 as a WASH-targeting miRNA. miR-637 mimic strongly attenuated the downstream IL-8 production and tumor sphere formation in esophageal cancer cells, whereas miR-637 inhibitor displayed an opposite effect. IL-8 could facilitate stem-like properties and partially rescue the phenotypes induced by miR-637 mimic. Furthermore, miR-637 inhibitor dramatically promoted IL-8 expression and cancer stemness properties in a WASH-dependent manner. Ectopic expression of miR-637 also inhibited tumor growth in a mouse model. Clinically, low expression of miR-637 was observed in tumor tissues and the low expression levels of miR-637 were correlated with poor survival of ESCC patients. In particular, plasma miR-637 could be used as a noninvasive biomarker for ESCC patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These results implicate the potential application of miR-637 for diagnosis and prognosis of esophageal cancer.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40364-022-00424-x","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T22:02:33Z","timestamp":1667512953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Loss of miR-637 promotes cancer cell stemness via WASH\/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma"],"prefix":"10.1186","volume":"10","author":[{"given":"Mengxing","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qitai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"issue":"6","key":"424_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"424_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","volume":"64","author":"M Arnold","year":"2015","unstructured":"Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381\u20137.","journal-title":"Gut."},{"issue":"8","key":"424_CR3","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1007\/s10620-018-5068-6","volume":"63","author":"AP Thrift","year":"2018","unstructured":"Thrift AP. Barrett's esophagus and esophageal adenocarcinoma: how common are they really? Dig Dis Sci. 2018;63(8):1988\u201396.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"424_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cgh.2018.07.018","volume":"17","author":"J Dong","year":"2019","unstructured":"Dong J, Gu X, El-Serag HB, Thrift AP. Underuse of surgery accounts for racial disparities in esophageal Cancer survival times: a matched cohort study. Clin Gastroenterol Hepatol. 2019;17(4):657\u201365.e13.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"26","key":"424_CR5","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMra1314530","volume":"371","author":"AK Rustgi","year":"2014","unstructured":"Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med. 2014;371(26):2499\u2013509.","journal-title":"N Engl J Med"},{"issue":"10110","key":"424_CR6","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(17)31462-9","volume":"390","author":"J Lagergren","year":"2017","unstructured":"Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390(10110):2383\u201396.","journal-title":"Lancet."},{"issue":"Suppl","key":"424_CR7","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1038\/ng1799","volume":"38","author":"J Kr\u00fctzfeldt","year":"2006","unstructured":"Kr\u00fctzfeldt J, Poy MN, Stoffel M. Strategies to determine the biological function of microRNAs. Nat Genet. 2006;38(Suppl):S14\u20139.","journal-title":"Nat Genet"},{"key":"424_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1476-4598-6-60","volume":"6","author":"WC Cho","year":"2007","unstructured":"Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007;6:60.","journal-title":"Mol Cancer"},{"key":"424_CR9","doi-asserted-by":"crossref","unstructured":"Bezzi M, Guarnerio J, Pandolfi PP. A circular twist on microRNA regulation. Cell Res 2017;27(12):1401\u20131402.","DOI":"10.1038\/cr.2017.136"},{"key":"424_CR10","doi-asserted-by":"crossref","unstructured":"Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNAs in the pathogenesis of hepatocellular carcinoma: a review. Cancers (Basel). 2021;13(3):514.","DOI":"10.3390\/cancers13030514"},{"issue":"1","key":"424_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40164-021-00206-5","volume":"10","author":"B Dong","year":"2021","unstructured":"Dong B, Li S, Zhu S, Yi M, Luo S, Wu K. MiRNA-mediated EMT and CSCs in cancer chemoresistance. Exp Hematol Oncol. 2021;10(1):12.","journal-title":"Exp Hematol Oncol"},{"issue":"21","key":"424_CR12","doi-asserted-by":"publisher","first-page":"24037","DOI":"10.18632\/aging.203665","volume":"13","author":"L Wang","year":"2021","unstructured":"Wang L, Ji XB, Wang LH, Xia ZK, Xie YX, Liu WJ, et al. MiRNA-30e downregulation increases cancer cell proliferation, invasion and tumor growth through targeting RPS6KB1. Aging (Albany NY). 2021;13(21):24037\u201349.","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"424_CR13","first-page":"3594","volume":"11","author":"X Tan","year":"2021","unstructured":"Tan X, Ren S, Fu MZ, Ren S, Yang C, Wu X, et al. microRNA-196b promotes esophageal squamous cell carcinogenesis and chemoradioresistance by inhibiting EPHA7, thereby restoring EPHA2 activity. Am J Cancer Res. 2021;11(7):3594\u2013610.","journal-title":"Am J Cancer Res"},{"key":"424_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.605894","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Han J, Liu Y, Hu J, Li M, Chen X, et al. miR-17-5p and miR-4443 promote esophageal squamous cell carcinoma development by targeting TIMP2. Front Oncol. 2021;11:605894.","journal-title":"Front Oncol"},{"issue":"11","key":"424_CR15","doi-asserted-by":"publisher","first-page":"19199","DOI":"10.1002\/jcp.28656","volume":"234","author":"Z Bahmanpour","year":"2019","unstructured":"Bahmanpour Z, Sheervalilou R, Choupani J, Shekari Khaniani M, Montazeri V, Mansoori DS. A new insight on serum microRNA expression as novel biomarkers in breast cancer patients. J Cell Physiol. 2019;234(11):19199\u2013211.","journal-title":"J Cell Physiol"},{"key":"424_CR16","doi-asserted-by":"crossref","unstructured":"Fujihara S, Kobara H, Nishiyama N, Hirose K, Iwama H, Masaki T. MicroRNA expression profiles in superficial esophageal squamous cell carcinoma before endoscopic submucosal dissection: a pilot study. Int J Mol Sci. 2021;22(9):4798.","DOI":"10.3390\/ijms22094789"},{"issue":"14","key":"424_CR17","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1242\/jcs.199570","volume":"130","author":"O Alekhina","year":"2017","unstructured":"Alekhina O, Burstein E, Billadeau DD. Cellular functions of WASP family proteins at a glance. J Cell Sci. 2017;130(14):2235\u201341.","journal-title":"J Cell Sci"},{"issue":"8","key":"424_CR18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/cr.2014.85","volume":"24","author":"P Xia","year":"2014","unstructured":"Xia P, Wang S, Huang G, Du Y, Zhu P, Li M, et al. RNF2 is recruited by WASH to ubiquitinate AMBRA1 leading to downregulation of autophagy. Cell Res. 2014;24(8):943\u201358.","journal-title":"Cell Res"},{"key":"424_CR19","doi-asserted-by":"crossref","unstructured":"Farina F, Ramkumar N, Brown L, Samandar Eweis D, Anstatt J, Waring T, et al. Local actin nucleation tunes centrosomal microtubule nucleation during passage through mitosis. EMBO J. 2019;38(11):e99843.","DOI":"10.15252\/embj.201899843"},{"key":"424_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ceb.2018.08.006","volume":"56","author":"B Simonetti","year":"2019","unstructured":"Simonetti B, Cullen PJ. Actin-dependent endosomal receptor recycling. Curr Opin Cell Biol. 2019;56:22\u201333.","journal-title":"Curr Opin Cell Biol"},{"issue":"9","key":"424_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107721","volume":"31","author":"GFW Walpole","year":"2020","unstructured":"Walpole GFW, Plumb JD, Chung D, Tang B, Boulay B, Osborne DG, et al. Inactivation of rho GTPases by Burkholderia cenocepacia induces a WASH-mediated actin polymerization that delays phagosome maturation. Cell Rep. 2020;31(9):107721.","journal-title":"Cell Rep"},{"issue":"12","key":"424_CR22","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1111\/cas.13400","volume":"108","author":"L Huang","year":"2017","unstructured":"Huang L, Lian J, Chen X, Qin G, Zheng Y, Zhang Y. WASH overexpression enhances cancer stem cell properties and correlates with poor prognosis of esophageal carcinoma. Cancer Sci. 2017;108(12):2358\u201365.","journal-title":"Cancer Sci"},{"issue":"10","key":"424_CR23","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1349-7006.2010.01654.x","volume":"101","author":"S Kurisu","year":"2010","unstructured":"Kurisu S, Takenawa T. WASP and WAVE family proteins: friends or foes in cancer invasion? Cancer Sci. 2010;101(10):2093\u2013104.","journal-title":"Cancer Sci"},{"issue":"3","key":"424_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.celrep.2013.07.007","volume":"4","author":"D Ishihara","year":"2013","unstructured":"Ishihara D, Dovas A, Hernandez L, Pozzuto M, Wyckoff J, Segall JE, et al. Wiskott-Aldrich syndrome protein regulates leukocyte-dependent breast cancer metastasis. Cell Rep. 2013;4(3):429\u201336.","journal-title":"Cell Rep"},{"issue":"3","key":"424_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/path.5086","volume":"245","author":"HT Morris","year":"2018","unstructured":"Morris HT, Fort L, Spence HJ, Patel R, Vincent DF, Park JH, et al. Loss of N-WASP drives early progression in an Apc model of intestinal tumourigenesis. J Pathol. 2018;245(3):337\u201348.","journal-title":"J Pathol"},{"issue":"38","key":"424_CR26","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1038\/onc.2014.419","volume":"34","author":"T Que","year":"2015","unstructured":"Que T, Song Y, Liu Z, Zheng S, Long H, Li Z, et al. Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1. Oncogene. 2015;34(38):4952\u201363.","journal-title":"Oncogene."},{"key":"424_CR27","doi-asserted-by":"crossref","unstructured":"Wang W, Zhao Z, Han S, Wu D. miR-637 prevents glioblastoma progression by interrupting ZEB2\/WNT\/beta-catenin cascades. Cell Mol Neurobiol. 2021;42(7):2321\u201335.","DOI":"10.1007\/s10571-021-01107-1"},{"issue":"2","key":"424_CR28","first-page":"567","volume":"23","author":"YM Du","year":"2019","unstructured":"Du YM, Wang YB. MiR-637 inhibits proliferation and invasion of hepatoma cells by targeted degradation of AKT1. Eur Rev Med Pharmacol Sci. 2019;23(2):567\u201375.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"424_CR29","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/hep.24595","volume":"54","author":"JF Zhang","year":"2011","unstructured":"Zhang JF, He ML, Fu WM, Wang H, Chen LZ, Zhu X, et al. Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. Hepatology. 2011;54(6):2137\u201348.","journal-title":"Hepatology."},{"key":"424_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.664916","volume":"11","author":"K Gao","year":"2021","unstructured":"Gao K, Chen S, Yang X. HOTTIP enhances gemcitabine and cisplatin resistance through sponging miR-637 in cholangiocarcinoma. Front Oncol. 2021;11:664916.","journal-title":"Front Oncol"},{"issue":"9","key":"424_CR31","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/s41388-018-0533-4","volume":"38","author":"M Shimizu","year":"2019","unstructured":"Shimizu M, Tanaka N. IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells. Oncogene. 2019;38(9):1520\u201333.","journal-title":"Oncogene."},{"issue":"1","key":"424_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/stem.2492","volume":"35","author":"F Liotti","year":"2017","unstructured":"Liotti F, Collina F, Pone E, La Sala L, Franco R, Prevete N, et al. Interleukin-8, but not the related chemokine CXCL1, sustains an autocrine circuit necessary for the properties and functions of thyroid Cancer stem cells. Stem Cells. 2017;35(1):135\u201346.","journal-title":"Stem Cells"},{"issue":"5","key":"424_CR33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41419-021-03680-1","volume":"12","author":"SJ Yang","year":"2021","unstructured":"Yang SJ, Wang DD, Zhong SL, Chen WQ, Wang FL, Zhang J, et al. Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637\/Akt1\/beta-catenin (cyclin D1) axis. Cell Death Dis. 2021;12(5):420.","journal-title":"Cell Death Dis"},{"issue":"5","key":"424_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3322\/caac.21244","volume":"64","author":"I Berindan-Neagoe","year":"2014","unstructured":"Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014;64(5):311\u201336.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"424_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","volume":"11","author":"H Schwarzenbach","year":"2014","unstructured":"Schwarzenbach H, Nishida N, Calin GA, Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 2014;11(3):145\u201356.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"424_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.canlet.2016.07.002","volume":"381","author":"R Singh","year":"2016","unstructured":"Singh R, Ramasubramanian B, Kanji S, Chakraborty AR, Haque SJ, Chakravarti A. Circulating microRNAs in cancer: Hope or hype? Cancer Lett. 2016;381(1):113\u201321.","journal-title":"Cancer Lett"},{"issue":"8","key":"424_CR37","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1038\/bjc.2014.451","volume":"111","author":"S Komatsu","year":"2014","unstructured":"Komatsu S, Ichikawa D, Hirajima S, Kawaguchi T, Miyamae M, Okajima W, et al. Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma. Br J Cancer. 2014;111(8):1614\u201324.","journal-title":"Br J Cancer"},{"issue":"4","key":"424_CR38","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/bjc.2011.588","volume":"106","author":"H Konishi","year":"2012","unstructured":"Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, Takeshita H, et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer. 2012;106(4):740\u20137.","journal-title":"Br J Cancer"},{"issue":"10","key":"424_CR39","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1111\/cas.15067","volume":"112","author":"W Panvongsa","year":"2021","unstructured":"Panvongsa W, Siripoon T, Worakitchanon W, Arsa L, Trachu N, Jinawath N, et al. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma. Cancer Sci. 2021;112(10):4257\u201369.","journal-title":"Cancer Sci"},{"issue":"9","key":"424_CR40","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1158\/1078-0432.CCR-20-1319","volume":"27","author":"A Teijeira","year":"2021","unstructured":"Teijeira A, Garasa S, Ochoa MC, Villalba M, Olivera I, Cirella A, et al. IL8, neutrophils, and NETs in a collusion against Cancer immunity and immunotherapy. Clin Cancer Res. 2021;27(9):2383\u201393.","journal-title":"Clin Cancer Res"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-022-00424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-022-00424-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-022-00424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T06:09:23Z","timestamp":1728281363000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-022-00424-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["424"],"URL":"https:\/\/doi.org\/10.1186\/s40364-022-00424-x","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]},"assertion":[{"value":"17 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were approved by the Institutional Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Approval number: 2019-KY-255). The animal study was approved by the Animal Care and Use Committee of Zhengzhou University (Approval number: ZZU-LAC20200807).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}